XML 113 R87.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Other Consolidated Financial Statement Detail (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Other Income (Expense), Net          
Interest income $ (20.1) $ (75.9) $ (37.5) $ (156.8)  
Interest expense 61.3 49.1 130.5 111.6  
(Gains) losses on investments, net 30.7 (105.4) 61.3 (27.7)  
Foreign exchange (gains) losses, net 11.3 8.7 20.7 19.4  
Other, net 2.0 2.3 3.9 1.7  
Other (income) expense 85.2 (121.2) 178.9 (51.8)  
Equity Securities, FV-NI, Gain (Loss), Alternative [Abstract]          
Net (gains) losses recognized on equity securities 30.4 (106.5) 61.0 (28.4)  
Less: Net (gains) losses realized on equity securities 0.6 (0.7) 5.5 0.9  
Net unrealized (gains) losses recognized on equity securities 29.8 (105.8) 55.5 (29.3)  
Accrued Expenses and Other          
Revenue-related reserves for discounts and allowances 1,116.0   1,116.0   $ 1,062.0
Employee compensation and benefits 228.3   228.3   335.1
Collaboration expense 319.4   319.4   214.6
Royalties and licensing fees 193.0   193.0   191.5
Reata related accrued expense 77.4   77.4   117.5
Other 689.5   689.5   838.4
Total accrued expense and other 2,472.1   2,472.1   2,623.6
Ionis, Sangamo, Denali and Sage          
Equity Securities, FV-NI, Gain (Loss), Alternative [Abstract]          
Net unrealized (gains) losses recognized on equity securities 51.4 $ 117.7 68.3 $ 78.0  
Component of accrued expenses and other          
Accrued Expenses and Other          
Revenue-related reserves for discounts and allowances $ 964.5   $ 964.5   $ 926.5